Skip to content
-
NewsnReleases

Financial news, corporate announcements, analysts’ reports

  • Home
  • EuronextCompanies announcement and press releases filed on Euronext
  • Australian ExchangeFinance, Insurance, Banking, Forex, Equity Markets
  • London Stock Exchange
  • WireNews Wire, Press Releases, Business Releases
  • Business & FinanceBlog
  • Contact Us
Posted inWire

CareDx to acquire oncology diagnostics company Naveris for up to $260 million

BRISBANE: CareDx Inc. has agreed to acquire precision oncology diagnostics company Naveris for up to $260 million, expanding its testing services beyond transplant medicine into cancer monitoring. The deal includes…
Posted by Muhammad ALI April 29, 2026
Posted inWire

Natera to buy Foresight Diagnostics in $450 million oncology tech deal

AUSTIN - Natera Inc has acquired Foresight Diagnostics, a move that expands its portfolio of tests that detect trace amounts of cancer left after treatment, in a deal worth up…
Posted by NNR December 7, 2025
Posted inAustralian Exchange

TrivarX to acquire brain imaging tech from Nucleics

SYDNEY: TrivarX Ltd (ASX: TRI) said on Thursday it will acquire the intellectual property for Stabl-Im™, a novel brain cancer imaging technology, from Australian biotech firm Nucleics Pty Ltd, in…
Posted by NNR October 16, 2025
Posted inWire

Irish Biotech Aerska raises $21 million to advance RNA therapies for brain diseases

DUBLIN: Irish biotechnology start-up Aerska has secured $21 million (€18 million) in seed funding to accelerate the development of RNA-based therapies targeting degenerative neurological diseases such as Alzheimer’s and Parkinson’s.…
Posted by NNR October 1, 2025
Posted inWire

Tempus AI acquires Paige to accelerate oncology AI innovation

CHICAGO: Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence-driven precision medicine, announced Friday it has acquired Paige, a digital pathology company known for pioneering FDA-cleared AI applications in…
Posted by NNR August 23, 2025
Posted inLondon Stock Exchange

Diaceutics Plc reports 22% H1 revenue growth; Boosts recurring income

LONDON: Diaceutics PLC (AIM: DXRX), a technology provider for pharmaceutical and biotech companies, announced strong first-half revenue growth driven by increased demand for its precision medicine commercialization services. Revenue rose…
Posted by NNR July 22, 2025
Posted inLondon Exchange

RenalytixAI, AstraZeneca to develop and launch precision medicine strategies

Parties to adopt multi-phase approach to develop precision medicine strategies to optimize treatment of cardiovascular, renal and metabolic disease NEW YORK: Renalytix AI plc announced a collaboration with AstraZeneca to…
Posted by NNR August 21, 2020
Site Navigation
  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About NewsnReleases

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.

Listed Companies

Equity Markets and Stock Exchanges

NNR

Scroll to Top
Go to mobile version